A Multicenter, Open-Label Continuation Trial Evaluating the Tolerability and Activity of Depsipeptide (FK228) in Patients That Have Completed a Prior Clinical Study With Depsipeptide.

NCT00299351 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

8

Enrollment

OTHER

Sponsor class

Conditions

Peripheral T Cell Lymphoma (PTCL)

Interventions

DRUG: Depsipeptide

Sponsor

Royal Marsden NHS Foundation Trust